DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
5,580.00
+90.00 (1.64%)
At close: Oct 2, 2025
DongKoo Bio & Pharma Market Cap
DongKoo Bio & Pharma has a market cap or net worth of 150.62 billion as of October 10, 2025. Its market cap has decreased by -4.05% in one year.
Market Cap
150.62B
Enterprise Value
230.64B
Revenue
242.55B
Ranking
n/a
PE Ratio
25.49
Stock Price
5,580.00
Market Cap Chart
Since February 19, 2018, DongKoo Bio & Pharma's market cap has decreased from 369.75B to 150.62B, a decrease of -59.26%. That is a compound annual growth rate of -11.08%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 150.62B | 14.94% |
Dec 30, 2024 | 131.05B | -16.18% |
Dec 28, 2023 | 156.35B | -7.82% |
Dec 29, 2022 | 169.61B | -27.07% |
Dec 30, 2021 | 232.56B | -3.34% |
Dec 30, 2020 | 240.58B | 49.11% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Feb 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 579.68T |
SK hynix | 273.06T |
LG Energy Solution | 93.37T |
Samsung Biologics | 71.81T |
Hanwha Aerospace | 56.44T |
Hyundai Motor Company | 48.05T |
HD Hyundai Heavy Industries | 46.87T |
KB Financial Group | 42.53T |